Leaders from University Hospitals joined a select few of the nation’s leading healthcare systems at a White House forum on patient and workforce safety as part of World Patient Safety Day on September 17.
Reporters are invited to this live event on Obesity Management and Kidney Health. Experts from the American Society of Nephrology will take questions on the inaugural Kidney Health Guidance on managing obesity in kidney disease patients
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Ms. Candy Dolan as the 2024 Outstanding Service Award recipient for her dedicated service to her patients, technologists, residents and fellows, and AANEM.
During the European Society for Medical Oncology (ESMO) Congress, Saby George, MD, FACP, of Roswell Park Comprehensive Cancer Center presented findings on a novel two-agent treatment that more than doubled progression-free survival compared with single-agent treatment.
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center.
A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced HER2-positive breast cancer. Research led by Dana-Farber Cancer Institute.
In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the addition of the immune checkpoint inhibitor (ICI) nivolumab to treatment with tivozanib for patients with advanced clear cell renal cell carcinoma.
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Devon I. Rubin as the 2024 Innovation Award recipient for his forward-thinking contributions to the neuromuscular (NM) and electrodiagnostic (EDX) community.
Novel treatments, including targeted therapies and antibody drug conjugates, as well as research into improving quality of life for patients with breast cancer, headline studies led by Dana-Farber Cancer Institute and presented at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.
CRI is co-hosting CICON24 to illuminate pioneering advances in cancer immunotherapy research starting September 8 in National Harbor, MD.
The STEM San Joaquin Conference, formerly known as San Joaquin Expanding Your Horizons, invites students grades 6-9 to register for its annual event happening on Saturday, Oct. 5, at the University of the Pacific in Stockton.
Hackensack Meridian Health Foundation to Honor Peter Cancro and Eli Manning at Annual Gala and Launch Be The Difference Campaign on September 14 at Lincoln Center
The American Society for Radiation Oncology (ASTRO) announced today the seven studies to be highlighted in the 2024 ASTRO Annual Meeting press program. Researchers will discuss their findings in news briefings held September 30 and October 1 at the Walter E. Washington Convention Center in Washington, D.C. and via live webcast.
Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at ASTRO 2024 – the American Society for Radiation Oncology’s annual meeting Sept. 29 – Oct. 2 in Washington D.C. Below are titles for oral presentations, posters and special sessions in which our researchers will be involved.
The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI), a Mount Sinai-led global team of researchers has shown.
The 14th annual Markesbery Symposium on Aging and Dementia is set for Sept. 27-28. The symposium, hosted by UK’s Sanders-Brown Center on Aging, is named in honor and memory of the late William R. Markesbery, M.D., the founding director of Sanders-Brown.
Cardiac physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will share new research and clinical insights at the European Society of Cardiology Congress in London Aug. 30 through Sept. 2.
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Shawn J. Bird as the 2024 Jun Kimura Outstanding Educator Award recipient for his numerous NM and EDX-related contributions.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
